glp-1 drugs key developments 2025 Receptor Agonist Market Valued at USD 62.86 Billion in 2025, Set to Grow at 17.5% CAGR Through 2034 Understanding GLP-1s and their dynamic
Description
Obesity as a Chronic Disease.
doi: 10.1530/JOE-23-0226
Prescription GLP-1 medications such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) mimic the rise in this hormone to slow down digestion and prompt you to stop eating
But the results for aleniglipron were very encouraging
Its mechanism involves reducing hepatic glucose production and improving insulin sensitivity, which indirectly affects appetite and fat storage
N.CorbinW
